Back
RiverNorth Opportunities Fund Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
72
RIV
RiverNorth Opportunities Fund
Last Price:
$11.70
Seasonality Move:
-3.12%
Buy
64
LYEL
Lyell Immunopharma, Inc.
Last Price:
$38.36
Seasonality Move:
-16.78%
Buy
72
RiverNorth Opportunities Fund (RIV)
is a Buy
Is RiverNorth Opportunities Fund a Buy, Sell or Hold?
-
The current RiverNorth Opportunities Fund [RIV] share price is $11.67. The Score for RIV is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RIV Stock Price Chart
What is RiverNorth Opportunities Fund's stock price today?
-
The RiverNorth Opportunities Fund share price today is $11.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIV is experiencing slight selling pressure.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.
RIV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.6 | Buy |
| Relative Strength Index (14 RSI): | 49.62 | Sell |
| Chaikin Money Flow: | -30026 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.4 - 11.84) | Buy |
| Bollinger Bands (100): | (11.55 - 12.27) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.08 | Buy |
| Relative Strength Index (14 RSI): | 79.16 | Buy |
| Chaikin Money Flow: | -97373 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.11 - 32.35) | Buy |
| Bollinger Bands (100): | (10.77 - 23.75) | Buy |
RIV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.73 | Sell |
| 20-day SMA: | 11.71 | Sell |
| 50-day SMA: | 11.61 | Buy |
| 200-day SMA: | 11.88 | Sell |
| 8-day EMA: | 7.41 | Buy |
| 20-day EMA: | 3.86 | Buy |
| 50-day EMA: | 1.73 | Buy |
| 200-day EMA: | 0.46 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.51 | Buy |
| 20-day SMA: | 28.33 | Buy |
| 50-day SMA: | 21.67 | Buy |
| 200-day SMA: | 13.52 | Buy |
| 8-day EMA: | 33.02 | Buy |
| 20-day EMA: | 28.99 | Buy |
| 50-day EMA: | 23.45 | Buy |
| 200-day EMA: | 17.42 | Buy |
RiverNorth Opportunities Fund Earnings Growth & RIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
RiverNorth Opportunities Fund Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||